BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 11149724)

  • 1. Improved survival in severe acquired aplastic anemia of childhood.
    Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
    Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
    Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
    Arranz R; Conde E; Rodriguez-Salvanés F; Pajuelo FJ; Cabrera R; Sanz MA; Petit J; Bueno J; Maldonado J; Odriozola J; Conde JG; Brunet S; Carreras E; Iriondo A; Fernández-Rañada JM; Marín P;
    Bone Marrow Transplant; 2002 Feb; 29(3):205-11. PubMed ID: 11859392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe acquired aplastic anemia in children: 11-year experience with bone marrow transplantation and immunosuppressive therapy.
    Halpérin DS; Grisaru D; Freedman MH; Saunders EF
    Am J Pediatr Hematol Oncol; 1989; 11(3):304-9. PubMed ID: 2675660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia.
    Werner EJ; Stout RD; Valdez LP; Harris RE
    Pediatrics; 1989 Jan; 83(1):61-5. PubMed ID: 2642621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
    Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
    N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allogenic hematopoietic stem cell transplantation in acquired aplastic anemia: first experience of the National Center for Bone Marrow Grafting].
    Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A
    Tunis Med; 2001 Oct; 79(10):498-502. PubMed ID: 11910688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience in the use of allogeneic bone marrow transplantation in severe forms of aplastic anemia at the Byelorussian hematological center].
    Uss AL; Zmachinskiĭ VA; Milanovich NF; Skriagin AE; Batan ZE; Dziuba EV; Mitskevich PB; Smirnova LA
    Ter Arkh; 1999; 71(7):69-72. PubMed ID: 10481871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.
    Arranz R; Otero MJ; Ramos R; Steegmann JL; Lamana ML; Tomás JF; de la Cámara R; Figuera A; Vázquez L; Fernádez-Rañada JM
    Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.
    Osugi Y; Yagasaki H; Sako M; Kosaka Y; Taga T; Ito T; Yamamoto M; Ohara A; Sato T; Mimaya J; Tsukimoto I; Kojima S;
    Haematologica; 2007 Dec; 92(12):1687-90. PubMed ID: 18055993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow transplantation for severe aplastic anemia].
    Bullorsky EO; Bonduel M; Shanley C; Figueroa C; Stemmelin G; Del Pozo A; Ceresetto J; Delfino S; Puppo M; Muriel FS
    Medicina (B Aires); 1998; 58(2):130-4. PubMed ID: 9706244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
    Pongtanakul B; Das PK; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients.
    George B; Mathews V; Viswabandya A; Lakshmi KM; Srivastava A; Chandy M
    Pediatr Hematol Oncol; 2010 Mar; 27(2):122-31. PubMed ID: 20201693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant].
    Barriga C F; Wietstruck P A; Becker K A; Zúñiga C P; Besa De C P; Alvarez Z M; Ocqueteau T M; Bertín C P
    Rev Med Chil; 2007 Nov; 135(11):1421-8. PubMed ID: 18259653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
    Storb R; Blume KG; O'Donnell MR; Chauncey T; Forman SJ; Deeg HJ; Hu WW; Appelbaum FR; Doney K; Flowers ME; Sanders J; Leisenring W
    Biol Blood Marrow Transplant; 2001; 7(1):39-44. PubMed ID: 11215697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
    Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H
    N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-laboratory variants of the course and results of therapy of hepatitis-associated aplastic anemias in children].
    Novichkova GA; Maschan MA; Kravchenko EG; Baĭdil'dina DD; Bogacheva NIu; Goronkova OV; Zharikova LI; Litvinov DV; Solopova GG; Suntsova EV; Shneĭder MM; Khachatrian LA; Skorobogatova EV; Shipitsyna IP; Trakhtman PE; Balashov DN; Maschan AA
    Ter Arkh; 2007; 79(7):57-61. PubMed ID: 17802792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.